Výsledky vyhledávání - Yasuhito Fujisaka
- Zobrazuji výsledky 1 - 3 z 3
-
1
A Phase I Dose-Escalation Study of ZD6474 in Japanese Patients with Solid, Malignant Tumors Autor Tomohide Tamura, Hironobu Minami, Yasuhide Yamada, Noboru Yamamoto, Tatsu Shimoyama, Haruyasu Murakami, Atsushi Horiike, Yasuhito Fujisaka, Tetsu Shinkai, Makoto Tahara, Kenji Kawada, Hiromichi Ebi, Yasutsuna Sasaki, Haiyi Jiang, Nagahiro Saijo
Vydáno 2006Artigo -
2
Long-term follow-up and exploratory analysis of lenvatinib in patients with metastatic or recurrent thymic carcinoma: Results from the multicenter, phase 2 REMORA trial Autor Seiji Niho, Jun Sato, Miyako Satouchi, Shoichi Itoh, Yusuke Okuma, Hidenori Mizugaki, Haruyasu Murakami, Yasuhito Fujisaka, Toshiyuki Kozuki, Kenichi Nakamura, Ryunosuke Machida, Yuichiro Ohe, Toshiyuki Tamai, Hiroki Ikezawa, Noboru Yamamoto
Vydáno 2024Artigo -
3
Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody Cetuximab Autor Kimio Yonesaka, Kreshnik Zejnullahu, Isamu Okamoto, Taroh Satoh, Federico Cappuzzo, John Souglakos, Dalia Ercan, Andrew M. Rogers, Massimo Roncalli, Masayuki Takeda, Yasuhito Fujisaka, Juliet Philips, Toshio Shimizu, Osamu Maenishi, Yong Gon Cho, Jason Sun, Annarita Destro, Koichi Taira, Koji Takeda, Takafumi Okabe, Jeffrey Swanson, Ito H, Minoru Takada, Eugene Lifshits, Kiyotaka Okuno, Jeffrey A. Engelman, Ramesh A. Shivdasani, Kazuto Nishio, Masahiro Fukuoka, Marileila Varella‐Garcia, Kazuhiko Nakagawa, Pasi A. Jänne
Vydáno 2011Artigo
Vyhledávací nástroje:
Související témata
Cancer
Internal medicine
Medicine
Adverse effect
Epidermal growth factor receptor
Gastroenterology
Oncology
Amphiregulin
Astrobiology
Biology
Cancer research
Cell biology
Cetuximab
Clinical trial
Colorectal cancer
Confidence interval
Dosing
EGFR inhibitors
ERBB3
Hazard ratio
KRAS
Lenvatinib
Neuregulin
Panitumumab
Pharmacokinetics
Pharmacology
Phases of clinical research
Physics
Receptor
Refractory (planetary science)